Announce Date | 05/08/2025 |
EPS Normalized Actual | $4.17 (Miss by $-0.55) |
EPS GAAP Actual | $4.17 (Miss by $-0.55) |
Revenue Actual | $2.39B |
Revenue Surprise | Beat by $2390M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 25.8013 | 1.8 | 24.93148 | 26.72275 | 1 |
Dec 2026 | 17.99333 | 2.58 | 14.18 | 23.25 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -3.761 | -3.761 | 2.39B | 96.9% | 2390M |
FQ4 2024 (Dec 2024) | 0 | 0 | 1.077B | 31.57% | 1077M |
FQ3 2024 (Sep 2024) | 0 | 0 | 2.018B | 42.02% | 2018M |
FQ2 2024 (Jun 2024) | 0.55 | 0.55 | 1.427B | 81.57% | 1427M |
FQ1 2024 (Mar 2024) | 0 | 0 | 0.074B | 100% | 74M |
FQ4 2023 (Dec 2023) | -14.15 | -14.15 | 0.737B | 100% | 737M |
FQ1 2015 (Mar 2015) | 0 | 0 | 2.239B | 100% | 2239M |
FQ2 2015 (Jun 2015) | 0 | 0 | 2.239B | 100% | 2239M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 7.20058 | -- | 7.20058 | 7.20058 | 5 |
FQ3 2028 (Sep 2028) | 7.14614 | -- | 7.14614 | 7.14614 | 5 |
FQ2 2028 (Jun 2028) | 7.14879 | -- | 7.14879 | 7.14879 | 6 |
FQ1 2028 (Mar 2028) | 6.18172 | -- | 6.18172 | 6.18172 | 3 |
FQ4 2027 (Oct 2027) | 6.5889 | -- | 6.5889 | 6.5889 | 2 |
FQ3 2027 (Jul 2027) | 6.5643 | -- | 6.5643 | 6.5643 | 2 |
FQ2 2027 (Jun 2027) | 6.56426 | -- | 6.35792 | 6.70827 | 2 |
FQ1 2027 (Mar 2027) | 6.35768 | -- | 6.15783 | 6.49716 | 2 |
FQ4 2026 (Oct 2026) | 5.835 | -- | 5.7044 | 5.9922 | 3 |
FQ3 2026 (Jul 2026) | 5.675 | -- | 5.54799 | 5.82789 | 3 |
FQ2 2026 (Jun 2026) | 5.715 | -- | 5.55051 | 5.85779 | 3 |
FQ1 2026 (Mar 2026) | 5.31 | 170.83 | 5.19115 | 5.45306 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 2.67B | -- | 2.67B | 2.67B | 2 |
FQ3 2028 (Sep 2028) | 2.67B | -- | 2.67B | 2.67B | 1 |
FQ2 2028 (Jun 2028) | 2.65B | -- | 2.65B | 2.65B | 1 |
FQ1 2028 (Mar 2028) | 2.62B | -- | 2.62B | 2.62B | 2 |
FQ4 2027 (Oct 2027) | 2.38B | -- | 2.38B | 2.38B | 2 |
FQ3 2027 (Jul 2027) | 2.39B | -- | 2.39B | 2.39B | 2 |
FQ2 2027 (Jun 2027) | 2.39B | -- | 2.33B | 2.43B | 4 |
FQ1 2027 (Mar 2027) | 2.37B | -- | 2.31B | 2.41B | 4 |
FQ4 2026 (Oct 2026) | 2.22B | -- | 2.19B | 2.27B | 2 |
FQ3 2026 (Jul 2026) | 2.24B | -- | 2.2B | 2.28B | 2 |
FQ2 2026 (Jun 2026) | 2.19B | -- | 2.14B | 2.23B | 2 |
FQ1 2026 (Mar 2026) | 2.24B | -6.51 | 2.21B | 2.29B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
2
EPS # of in-lines
5
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -3.761 | -3.761 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0.55 | 0.55 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | -14.15 | -14.15 | 100% | |
FQ1 2015 (Mar 2015) | 0 | 0 | NAN% | |
FQ2 2015 (Jun 2015) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.39B | $2390M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.08B | $1077M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.02B | $2018M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.43B | $1427M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.07B | $74M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.74B | $737M | 100% |
FQ1 2015 (Mar 2015) | $0B | $2.24B | $2239M | 100% |
FQ2 2015 (Jun 2015) | $0B | $2.24B | $2239M | 100% |